Exhibit 107

Calculation of Filing Fee Tables

Form S-3

(Form Type)

Ensysce Biosciences, Inc.

(Exact Name of Each Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

		Security Type		Security Class Title		Fee Calculation or Carry Forward Rule				Amount Registered⁽¹⁾				Proposed Maximum Offering Price Per Unit⁽²⁾				Maximum Aggregate Offering Price⁽²⁾				Fee Rate⁽²⁾				Amount of Registration Fee ⁽²⁾				Carry Forward Form Type				Carry Forward File Number				Carry Forward Initial effective date				Filing Fee previously Paid In Connection with Unsold Securities to be Carried Forward
		Newly Registered Securities
Fees to Be Paid		Equity		Common Stock, par value $0.0001 per share ("Common Stock") underlying warrants to purchase Common Stock ⁽³⁾			457(c)				2,112,000	(3)		$	1.61			$	3,400,320				0.00013810			$	469.58
Fees to Be Paid		Equity		Common Stock, par value $0.0001 per share ("Common Stock") underlying convertible Preferred Stock (3)			457(c)				2,487,000			$	1.61			$	4,004,070				0.00013810			$	552.96
Fees Previously Paid
		Carry Forward Securities
Carry Forward Securities
		Total Offering Amounts																$	7,404,390							$	1,022.55
		Total Fees Previously Paid																									-
		Total Fee Offsets																									-
		Net Fee Due																								$	1,022.55

(1)	The shares of the Registrant’s common stock, par value $0.0001 per share (the “Common Stock”), offered hereby also include such presently indeterminate number of shares of Common Stock as a result of stock splits, stock dividends or similar transactions in accordance with Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”).
(2)	Pursuant to Rule 457(c) under the Securities Act, and solely for the purpose of calculating the registration fee at a fee rate of 0.00013810 ($138.10 per $1 million), the proposed maximum offering price per share is $1.61, which is the average of the high and low prices of the Common Stock as reported on The Nasdaq Capital Market on November 24, 2025, which date is within five business days prior to filing this Registration Statement.
(3)	Represents an aggregate of 4,599,000 shares of common stock registered for sale by the selling stockholders named in this registration statement consisting of: 2,487,000 (1,094,078 shares plus an additional 1,392,922 reserved shares) shares of Common Stock issuable upon conversion of shares of the Company’s Series B Preferred Stock (the “Preferred Stock”), 2,000,000 (880,000 shares plus an additional 1,120,000 reserved shares) of Common Stock underlying those certain warrants (the “Investor Warrants”) issued by the Company pursuant to securities purchase agreement, 112,000 shares of Common Stock underlying those certain warrants issued to a financial advisor. The number of shares listed above includes shares of Common Stock reserved for possible adjustment to the conversion price of the Preferred Stock and Investor Warrants, all in certain private transactions described herein (after giving effect to certain potential anti-dilution and other adjustments).

N/A